Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

"Having good mentors is key, no matter what field you're in. I think it's wonderful that NDM are putting an official mentorship program in place, particularly for people who are shy or unable to stick up for themselves. Having someone who believes in you and can go in and bat for you is really important." - Professor Ellie Barnes, MRC Senior Research Fellow, Experimental Medicine and Jenner Investigator.

MRC Senior Research Fellow, Experimental Medicine and Jenner Investigator

Ellie BarnesFor successful Oxford immunologist and mother of two, Professor Ellie Barnes, one of the keys to happiness is having all the answers. From an inquisitive child to a science “obsessed” mother of two, Ellie started out in Medicine before taking on a PhD in 1999. After completing her PhD in Hepatitis C and T cell Immunology,  Ellie continued to focus her research on immune responses to therapy, before diving into translational work and vaccine development programs in HBV and HCV. In addition to her vaccine work Ellie is also leading an international MRC funded stratified medicine consortium called Stop HCV, a collaboration between 22 partners from around the UK (industry, scientists, and clinicians) integrating viral and host genetic datasets with immune parameters and clinical data and driving new clinical studies.

One of just three researchers in the UK to be awarded an MRC Senior Fellowship,  Ellie says she is feeling positive about her future in science, as the award will support her research group for the next 5 years. While Ellie admits she could not have maintained balance between work and home life without her husband “friend and advocate”, who takes an equal share in childcare, she also feels the support she has received from her colleagues, and the Nuffield Department of Medicine, has been critical.